Rebyota Found Safe, Effective in Preventing Recurring Clostridioides Difficile Infection
Treatment-emergent adverse events associated with Rebyota for Clostridioides difficile infection were more prevalent in those with renal comorbidities than in those without and were moderate in severity as well as related to pre-existing conditions.